RSS icon

Clinical demand

Greet Van den Berghe demonstrated that controlling patient glucose levels in the ICU within tight normal ranges yielded significant improvements in patient outcomes.

Discover what clinicians themselves have to say on the current need.

What they say

To safely target normoglycaemia in ICU, patients, intensivists and ICU nurses alike, anxiously await accurate continuous blood glucose sensors.
These devices (continuous or near continuous glucose monitors) offer the promise of a reduction in severe hypoglycemia, glycemic variability and the nursing work burden, and will probably become a cornerstone of SEGC.
We need better methods to monitor blood glucose levels at the bedside.
Most importantly, we need to improve the monitoring of blood glucose, from what is the primitive standard of once every 1-2 hrs. We must transition to continuous or near-continuous blood glucometry through a technology breakthrough.
Although most nurses endorse tight glycemic control, the work associated with it is burdensome and costly. Because up to 2 hours might be required for tight glycemic control for a single patient in a 24-hour period, the costs in time and money are high. Easier clinical methods for monitoring blood glucose levels are needed.
…better technology that would allow accurate glucose monitoring with minimal effort is required.

Resources

Information on TGC protocols and links to additional resources.

Read more

Platform technology

GlySure's team of scientists and engineers has a combined 150 years' experience of developing in-vivo fiber optic continuous monitoring sensors and systems.

Read more